EMINENCE ENT (00616) completed the issue of 67 million shares of placement shares.
Alpine Enterprises (00616) announced that all the conditions set out in the placement agreement have been met, and the completion of the placement was carried out on December 30, 2025 in accordance with the terms and conditions of the placement agreement. According to the placement agreement, the company has issued and distributed 67 million placement shares to 6 placees at a placement price of 0.30 Hong Kong dollars per share under the general mandate, equivalent to approximately 3.83% of the company's issued share capital (after the issuance and distribution of the placement shares).
EMINENCE ENT (00616) announced that all terms of the placement agreement have been met and the placement has been completed on December 30, 2025 in accordance with the terms and conditions of the agreement. Under the placement agreement, the company has issued and allocated 67 million placement shares to 6 subscribers at a placement price of HK$0.30 per share, representing approximately 3.83% of the enlarged issued share capital of the company as of the announcement date.
Related Articles
SIPAI HEALTH (00314) spent HK$814,700 to repurchase 330,000 shares on December 30th.
Guolian Minsheng (01456): Hui Yu will independently serve as the company secretary and authorized representative.
.png)
SCIENTECH(02291): Yang Lishan has been appointed as Joint Company Secretary.
SIPAI HEALTH (00314) spent HK$814,700 to repurchase 330,000 shares on December 30th.
Guolian Minsheng (01456): Hui Yu will independently serve as the company secretary and authorized representative.
SCIENTECH(02291): Yang Lishan has been appointed as Joint Company Secretary.
